AORTARTIVION, INC.
Surgical & Medical Instruments & Apparatus
- Revenue
- $441M
- 14% YoY
- Operating margin
- 7.6%
- 24% YoY
- EBITDA
- $56M
- 11% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 5.1×
- $286M net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear408% of net incomeCash flow under 80% of net income
- Dilutive SBCClear6% of revenueOver 10% of revenue
- Payouts exceed cash flowClear23% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear33% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $299M | $314M | $354M | $389M | $441M | 14% |
| Operating income | $8M | $6M | $6M | $39M | $34M | 13% |
| Net income | −$15M | −$19M | −$31M | −$13M | $10M | 173% |
| Operating cash flow | −$3M | −$5M | $19M | $22M | $40M | 79% |
| Capex | $13M | $11M | $10M | $11M | $39M | 249% |
| Stock-based comp | $11M | $12M | $14M | $14M | $24M | 71% |
Deal filings
None.
13D filers
None on file.
Insider trading
- Open-market buys, 12 mo
- $0 · 0
- Open-market sells, 12 mo
- $719K · 5
- Net
- −$719K
Pay vs performance
No pay-versus-performance disclosure yet.